Weeks 1 through 4: the adjustment phase Gastrointestinal side effects peak during the first month and with each subsequent dose increase
H.DiamantM.JolesJ
However, rapid weight loss can also cause changes in diet and digestion that might increase the risk of constipation, making hemorrhoids more likely to develop or worsen
Gallbladder Issues: Ozempic use has been associated with gallbladder inflammation and gallstone formation, prompting specific warnings due to changes in bile composition and cholesterol metabolism
Studies have shown that GLP-1R agonists are also able to reduce myocardial infarction, stroke and heart failure (Solini et al., 2023
Retatrutide, a triple GIP/GLP-1/glucagon receptor agonist, posted Phase III data in type 2 diabetes showing A1c reductions of 1.7 to 2.0 percentage points and average weight loss of 25 to 37 pounds across doses, per Dr